I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced publication of the ...

A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

Dr. Breelyn Wilky, director of sarcoma medical oncology at the University of Colorado Cancer Center, encourages patients with gastrointestinal stromal tumors (GIST) to seek expert care and stay ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

A report by the Chinese Anti-Cancer Association shows that lung and gastrointestinal cancers are the most prevalent among ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists.

As early-onset cancer diagnoses surge among young people, doctors and researchers are urgently exploring potential causes ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

Martin, who died this week of colon cancer at the age of 30, said his five-year battle began with a single symptom.

Dr. Breelyn Wilky discusses some of the most recent advancements in GIST treatment, as well as touched on the role of ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...